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e.2012.02Abstract Objective: To determine the cellular immune response in Bell’s palsy (BP) and its prog-
nostic value in relation to clinical and electrophysiological ﬁndings.
Methods: Twenty patients with BP were subjected to: Facial nerve paralysis assessment according to
House–Brackmann (H&B) grading system, bilateral facial nerve conduction study with electroneu-
rography (ENoG) quotient calculation, blink reﬂex, and needle electromyography (EMG) for the
affected side; one week from the onset. Before the start of medical treatment, peripheral blood mono-
nuclear cell subsets were analyzed to reveal the percentage of total T cells (CD3+), T helper/inducer
cells (CD4+), T cytotoxic (CD8+) and B cells (CD19+). Patients were followed up byH&B, ENoG
and needle EMG up to 3 months from the onset (end point). Fifteen age and sex matched healthy
control subjects for the electrophysiological study and laboratory tests were included.
Results: The percentages of CD3+, CD4+ & CD8+ were signiﬁcantly depressed in BP patients
than in control. CD19+ percentage did not show signiﬁcant difference between them. On follow
up, H&B revealed signiﬁcant improvement. Neither electrophysiological parameters nor ENoG
showed signiﬁcant difference between initial and follow up assessments. Initial CD4+ percentage
correlated negatively with disease duration. While Initial CD8+ percentage correlated positively
with follow up compound muscle action potential (CMAP) amplitude of orbicularis oris muscle
and ENoG of orbicularis oculi and nasalis muscles. Initial CD19+ percentage correlated negatively
with follow up H&B and R1 & R2 responses of follow up blink reﬂex. Initial CD3+ percentage did
not correlate with any of the follow up measures.(E.M. Shahine).
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234 N.A. El Sawy et al.Conclusion: Decreased percentage of peripheral blood CD3+, CD4+ & CD8+ in BP patients
emphasizes the role of cell mediated autoimmune pathogenesis in the acute stage of the disease.
These cells have a prognostic signiﬁcance for prediction of the disease duration and outcome. Anal-
ysis of T lymphocytes subsets may provide an additional parameter to differentiate patients with
favorable from those with poor prognosis.
ª 2012 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.1. Introduction
Bell’s palsy (BP) is primarily an acute 7th cranial nerve paral-
ysis that cannot be attributed to central or peripheral lesions,
systemic infections or inﬂammatory conditions.1 Several mech-
anisms have been proposed for the etiology of BP including
ischemia, autoimmune reaction and viral infection.2–6 Herpes
simplex 1 virus (HSV-1) was proved to be a cause of BP by sev-
eral studies.4,5,7,8 It is thought to persist as a latent infection.
Reactivation of a dormant HSV-1 within the geniculate gan-
glion (GG) and anterograde transport to facial nerve termini
with subsequent inﬂammation and entrapment of the facial
nerve at the meatal foramen was proposed as a pathogenic
mechanism in BP.1,9–12 Reactivation of a latent virus can be
triggered by surgical trauma, upper respiratory tract infection,
fever, dental extraction, emotional distress, exposure to cold,
metabolic disorders and immunosuppression.8,13 Among the
lymphocytes, the role of CD8+ T cells is established where
the reduced number of these cells is among the factors that
facilitate HSV-1 reactivation.14 Prevention of reactivation re-
quires a complex interplay among the virus, neurons and im-
mune response. An accumulating evidence supports the view
that CD8+ effector T cells employ both lytic granule (perfo-
rin)- and IFN c-dependant effector mechanisms in maintaining
HSV-1 latency.12 The exact role and timing of contribution of
lymphocyte subsets during HSV-1 reactivation is still uncer-
tain. On the other hand, a number of case reports have linked
recent primary oral HSV-1infection with unilateral15 or bilat-
eral16 facial paralysis. In primary HSV-1infection a strong im-
mune response evolves composed of virus neutralizing
antibodies and antiviral CD4+ and CD8+ T cell response
which efﬁciently inhibits virus replication with induction of
virus-speciﬁc immunity by the adaptive immune system.17,18
A concern of both patients with BP and their physicians is
when and how facial paralysis will be completely resolved.19
The underlying pathology of the facial nerve is the major prog-
nostic indicator in such patients i.e. demyelination favors a
good prognosis whereas axonal degeneration has a bad one.
Accordingly, it is assumed that the underlying immune response
will determine the severity of inﬂammation and nerve damage
and hence the prognosis of BP. Since lymphocytes are migra-
tory cells i.e. their distribution in the body reﬂects the rate at
which they enter and depart particular sites as well as their local
replication, thus these emigrating cells eventually are carried
into the bloodstream and trafﬁc among organs according to
their interaction with the target tissue.20 Therefore, in a clinical
setting as BP, it seems convenient to study the peripheral blood
lymphocytes subsets which reﬂects their dynamic activity and
hence the competence of the immune system. In this context,
several studies investigated the lymphocyte subsets in BP withcontroversial results.21–23 Therefore, this study aimed at identi-
fying the pattern of peripheral blood lymphocyte subsets in BP
patients compared to healthy controls and their relation to dis-
ease prognosis as assessed by functional and electrophysiologi-
cal outcome measures.
Study design: case-control prospective study.
2. Subjects and methods
Twenty patients; 11 males (55%) and 9 females (45%) with
unilateral BP were included in the study. Their ages ranged
between 7 and 55 years (mean ± SD: 28.9 ± 15.2). The diag-
nosis of BP was determined according to criteria described
by Taverner24: sudden onset, unilateral, complete or partial
paralysis of facial muscles; absence of symptoms and signs
attributable to nervous system diseases; absence of symptoms
and ﬁndings attributable to ear and posterior fossa lesions as
well as history of trauma to the head or surgery in the face
or the parotid region, diabetes mellitus, inﬁltrative disease
and history of irradiation to the neck. Patients with a previous
history of Bell’s palsy were excluded from the study.
The study also included 15 age and sex matched healthy con-
trol subjects (without a previous history of Bell’s palsy) for the
electrophysiological study and laboratory tests. The control
group was composed of 8 (53.3%) males and 7 (46.7%) females
with an age range of 9–53 years (mean 26.1 ± 10.9).
All patients were subjected to the following:
1. History taking including; demographic data: name, age,
sex, occupation, present history: mode of onset, duration
of the disease, herpetic eruptions.
2. Full neurological examination.25
3. Examination of facial muscles and their grading accord-
ing to facial nerve grading system of House-Brackman
(HB).26
4. Electrophysiological examination was performed at 10
to15 days of the disease onset27 which included the following:
a) Bilateral facial nerve motor conduction studies (for
patient and control groups):28
The facial nerve was stimulated below the ear anterior to the
mastoid. The active recording electrode was placed over the
frontalis, orbicularis occuli (OOc), nasalis and orbicularis oris
(OOr) muscles. The reference electrode was placed over the
standard corresponding point. The ground electrode was placed
at the wrist. The compound muscle action potential (CMAP)
latency and amplitude were recorded for each studied muscle.
In the patients’ group, the ratio of the amplitude of CMAP on
the affected side to that on the healthy side was calculated as
a percent (electroneurographic quotient i.e. ENoG quotient).
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involvement.29
ENoG quotient ¼ Amplitude of affected side
Amplitude of healthy side
 100
Regarding the control group, calculation of ENoG quotient
was carried out according to the following formula:
ENoG quotient ¼ side with smaller CMAP amplitude
side with larger CMAP amplitude
 100
b) Blink reﬂex:28
Recording was performed from both sides simultaneously
using 2 channels. Recording settings were: sweep speed
10 ms/division, gain 200 lV/division and analysis time 100 ms.
5. Needle electromyography (EMG) of OOc and OOr muscles
of the affected side was carried out after 10–15 days of the
onset.30 Patients with axonopathy should have both EMG
ﬁndings of axonal degeneration in the acute stage (denerva-
tion potentials and decreased recruitment) and ENoG less
than the mean-2SD of that of the control group, otherwise
demylination is considered.28
6. EDTA blood samples were obtained from all patients and
control group before the start of medical treatment. Periph-
eral blood lymphocyte subsets were analyzed with ﬂow
cytometry (Becton–Dickinson, Erembodegem, Belgium)
and monoclonal antibodies labeled with either ﬂuorescein
isothiocyanate or phycoerythrin (CD3/FITC, CD19/PRE,
CD4/FITC and CD8/PRE) to reveal the percentage of total
T cells (CD3+), B cells (CD19+), T helper/inducer cells
(CD4+) and T cytotoxic cells (CD8+).
All patients were treated within the ﬁrst 72 h of symptoms
onset, after obtaining blood sample, with oral acyclovir
(400 mg ﬁve times daily) and oral prednisolone (at a dose of
40–60 mg daily)31 that was gradually withdrawn.
Patients were followed up by HB grading system, facial
nerve motor conduction studies, ENoG, needle EMG and
assessment of T-cells percentage on recovery or up to 3 months
of the onset (as an end point).32 The study was approved by
the Local Ethics Committee, Faculty of Medicine, Alexandria
University. All patients and control groups were informed
about the nature of the study and written acceptance consent
was signed by each participant.
Statistics: Description of the sample was expressed as fre-
quencies and percentages. Distribution of all variables was
evaluated using Skewness test. All variables were normally dis-
tributed except for the initial and follow up latency and ampli-
tude of the affected OOc and OOr muscles respectively as well
as the initial and follow up peripheral blood CD3+ and
CD19+. For normally distributed variables, Student t test
was used to compare between patients and controls, while
paired t test was used for initial and follow up comparisons.
For other variables, Mann–Whitney test was used for compar-
ison between patients and controls and Wilcoxon test for ini-
tial and follow up comparison. Correlation between variables
was examined by Spearman’s test. SPSS v 11.0 was used to
perform the statistical analysis. Cut off values were calculatedas the mean ± 2SD of controls for electrophysiological
parameters. P is signiﬁcant if 60.05.
3. Results
No statistical signiﬁcant difference in age was found between
patients and controls (t= 0.578, P= 0.568). Eleven patients
(55%) had right side BP and 9 patients (45%) had left side
lesion. None of the patients complained of hyperacusis or
disturbed taste sensation i.e. all had distal facial nerve affec-
tion. The triggers for the disease as stated by the studied pa-
tients were exposure to cold, emotional stress and a
preceding upper respiratory tract infection. Mean disease fol-
low up duration was 5.36 ± 4.78 weeks. According to HB
grading system; 5 patients (25%) were grade II, 3 patients
(15%) were grade III, 5 patients (25%) were grade V, and 7 pa-
tients (35%) were grade VI at initial evaluation. On follow up
evaluation, 7 patients (35%) were grade I, 5 patients (25%)
were grade II, 2 patients (10%) were grade III, 3 patients
(15%) were grade V, and 3 patients (15%) were grade VI.
Table 1 shows the comparison between patients and controls
regarding the ENoG ﬁndings as well as the ENoG cut off val-
ues (mean of the control value-2SD) of the studied facial mus-
cles. There was a statistically signiﬁcant decrease of the ENoG
of frontalis, nasalis and OOr of patients compared to controls.
(p 6 0.05) (Fig. 1).
Table 2 shows the mean values of initial and follow up HB
grading system. A statistical signiﬁcant improvement was
found in HB grading system at follow up evaluation
(P= 0.001). It shows also the mean amplitude and latency
of the facial nerve CMAP recorded from the frontalis, OOc,
nasalis, OOr muscles of the affected side among the studied
patients at initial and follow up evaluation. Neither the mean
latency nor the mean amplitude of the recorded CMAP
showed a statistically signiﬁcant difference on comparing the
initial to the follow up assessment. Similarly, ENoG did not
show signiﬁcant difference between initial and follow up
values.
Individual data analysis revealed that 5 patients (25%) had
demylination pathology (they recovered completely before
3 months) and 15 patients (75%) had axonal lesion based on
cut off values of ENoG and EMG ﬁndings as well as the
follow up HB grading system. Table 3 shows the mean values
of peripheral CD3+, CD4+, CD8+ and CD19+ mononu-
clear cell subsets among patients and control groups at initial
evaluation. The initial percentage of CD3+, CD4+ & CD8+
subsets was signiﬁcantly depressed in BP patients group com-
pared to age matched control subjects (p 6 0.05). However, the
percentage of CD19+ subset did not show a signiﬁcant differ-
ence between patients and control groups (p= 0.69).
Moreover, comparison between BP patients with demyelin-
ating pathology and those with axonal lesion regarding the
mean initial percentage of peripheral blood T cells revealed no
statistical signiﬁcant difference (CD 4+; t= 0.6, p= 0.558,
CD8+; t= 1.596, p= 0.138 and CD3+; Z= 0.681,
p= 0.496), while there was a statistically signiﬁcant increase
in the mean initial percentage of CD19+ in patients with demy-
elination compared to those with axonopathy (Z= 2.632,
p= 0.008). Spearman’s correlation revealed a negative correla-
tion between the initial percentage of CD4+ subset with disease
follow up duration (r= 0.882, P = 0.02). Initial percentage
Table 1 Comparison of the electroneurography of the facial muscles between patients and controls.
Parameter Patients mean ± SD Control mean ± SD t p Cut oﬀ values
Electroneurography:
Frontalis 45.6 ± 30.4 73.7 ± 23.6 2.524 0.02* 26.5
Orbicularis occuli 51.1 ± 34.2 72.6 ± 16.6 1.975 0.066 41.4
Nasalis 49.3 ± 27.8 85.9 ± 10.8 4.307 0.001* 64.3
Orbicularis oris 47.3 ± 30.6 83 ± 11.3 3.602 0.003* 60.4
* Signiﬁcant if p 6 0.05.
Figure 1 Compound muscle action potential recorded from (a) frontalis, (b) orbicularis occuli, (c) nasalis (d) orbicularis oris muscles of
patient’s healthy (upper 2 traces) and affected sides (lower 2 traces).
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amplitude of OOr muscle (r= 0.841, P = 0.04) on the affected
side and positively with follow up ENoG of OOC and nasalis
muscles (r= 0.894, P= 0.04 for each). Initial percentage of
CD19+ subset correlated negatively with follow upHB grading
system (r=0.807,P = 0.003) and negatively with latencies of
ipsilateral R1, R2 and contralateral R2 responses of follow up
blink reﬂex on the affected side (r= 1.0, P= 0.001 for each).
Initial CD3+ percentage did not correlate with any of the fol-
low up measures.
4. Discussion
Among the proposed mechanisms underlying BP which may
be directly relevant to the immune system are the reactivation
of HSV-11,9–12 and the less commonly considered; the autoim-
mune mechanism.3,21 In the present study, the studied BP pa-
tients were assumed to have reactivation of a latent herpes
virus as a probable pathogenic mechanism. None of the stud-
ied patients was suffering from primary herpes infection (orany other illness) at the time of presentation of BP which ruled
out the possibility of the primary or recent HSV-1 infection
with concomitant BP. In the context of autoimmunity, Abram-
sky et al. suggested that in BP there is in vivo sensitization of
lymphocytes to self protein called neuritogenic basic protein
and concluded that an immunological process similar to Guil-
lian-Barr syndrome (GBS) occurs in BP and even the latter
could represent a mononeuritic variant of GBS.3 In the present
study neither speciﬁc viral nor speciﬁc neural markers were as-
sessed, therefore, both mechanisms will be adopted to explain
the results of the study.
Our study revealed a decrease of the mean percent of the
components of cellular immunity (CD8+, CD4+ and Total
CD3+) among the studied patients while CD19+ percent (B
cells) was slightly increased in patients though not statistically
signiﬁcant compared to control. The interactions between
viruses and the host immune system are not only complex
but also critical in determining the outcome of infection and
prevention strategies.33 In the target tissue (GG in BP) where
the virus resides in a latent state, inﬁltrating virus-speciﬁc
Table 2 Comparison of initial and follow up values of House and Brackmann grading system, affected facial
nerve CMAP latency and amplitude, electroneurography and blink reﬂex responses among patients.
Initial mean ± SD (n= 20) Follow up mean ± SD (n= 20) T P
House and Brackmann 4.5 ± 1.5 1.7 ± 1.4 4.66 0.001*
Facial nerve CMAP latency (ms):
Frontalis 3.3 ± 0.9 3.3 ± 0.6 0.4 0.69
Orbicularis occuli 3.4 ± 0.7 3.3 ± 0.7 0.6 (Z) 0.60
Nasalis 3.0 ± 0.6 3.0 ± 0.3 1.0 0.43
Orbicularis oris 2.6 ± 0.8 3.3 ± 0.9 2.0 0.13
Facial nerve CMAP amplitude (mV):
Frontalis 0.3 ± 0.3 0.7 ± 0.4 2.0 0.10
Orbicularis occuli 0.7 ± 0.6 0.8 ± 0.6 0.0 1.00
Nasalis 1.0 ± 0.7 1.3 ± 1.0 0.7 0.49
Orbicularis oris 2.6 ± 2.4 2.6 ± 2.3 0.7 (Z) 0.52
Electroneurography:
Frontalis 45.6 ± 30.4 67.5 ± 39.7 1.2 0.28
Orbicularis occuli 51.1 ± 34.2 60.8 ± 43.5 0.8 0.48
Nasalis 49.3 ± 27.8 53.8 ± 35.0 0.9 0.39
Orbicularis oris 47.3 ± 30.6 59.4 ± 39.6 0.6 0.56
Blink reﬂex:
R1 11.6 ± 0.5 10.1 ± 0.8 6.0 0.10
Ipsilateral R2 29.6 ± 3.6 31.3 ± 4.3 11.0 0.06*
Contralateral R2 31.4 ± 3.8 31.6 ± 3.4 4.7 0.13
* Signiﬁcant if p 6 0.05. Z: Wilcoxon test was used.
Table 3 Comparison of peripheral blood mononuclear cell
subsets between patients and control groups.
Patients (n= 20)
Mean ± SD
Controls (n= 15)
Mean ± SD
t P
CD3+ 62.4 ± 15.3 80.5 ± 7.7 4.1(Z) 0.001*
CD4+ 40.7 ± 6.2 47.9 ± 9.7 2.1 0.050*
CD8+ 21.7 ± 3.4 24.5 ± 2.5 2.4 0.023*
CD19+ 8.3 ± 5.6 7.5 ± 4.5 0.4(Z) 0.69
* Signiﬁcant if p 6 0.05. Z: Mann–Whitney statistics was used.
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inhibit HSV-1 reactivation.35–37 Although the role of CD4+ T
cells in viral latency was not well highlighted, yet it was shown
that the lack of CD4+ T cell’s help of CD8+ cells during the
primary infection leads to a transient inability to control the
latent virus with reduced functional avidity of ganglionic
HSV speciﬁc CD8+ cells.34,38 Under certain circumstances
HSV-1 reactivates with peripheral shedding of the infectious
virus.39 Stress-induced HSV-1 reactivation results from a tran-
sient compromise of CD8+ T cells surveillance.40 Thus, it ap-
pears that stressful stimuli virtually impair the T cell function
in the target tissue (not assessed in this study) and in the
peripheral circulation (assessed in this study) leading to de-
crease in their percent in the peripheral circulation. This may
explain our results (decreased components of cell mediated
immunity). In addition, the decline in the percentage of the im-
mune cells in blood may reﬂect the attempts of the cells to con-
trol viral reactivation which led to their migration from the
blood to the target.41 However, the possibility that decreased
percentage of these cells may result from virus-T cells exhaus-
tion and/or dysregulation cannot be excluded.42 In this con-
text, the concept of the relationship between facial paralysis
and immune suppression was adopted by some authors.43,44In the present study, comparing the initial T cell percentage
among patients with demyelination and those with axonal
degeneration revealed that both groups had comparable values
of T cells but patients with demyelination had a signiﬁcant in-
crease in the initial percentage of B cells which may account
for the relatively favorable prognosis of such patients.
Although the role of B cells was not well addressed in HSV-
1 latency and reactivation, yet some studies demonstrated
the beneﬁcial role of B cells in controlling the persistent viral
infection.45,46 Weck et al. observed that c herpes virus latency
was regulated by B cells and that the majority of the persis-
tently infected B-cell deﬁcient mice died between 100–200 days
post infection, whereas the normal control mice maintain the
virus in a latent state.45 Thus, the humoral responses act in
concert with cellular immunity to control primary and latent
viral infections.47 Therefore, it can be assumed that patients
with demyelinating facial nerve pathology (with increased per-
cent of CD19+) had a less inﬂammation, less edema around
the nerve, less compression and hence the possibility of axonal
degeneration is less. This deduction was supported by the neg-
ative correlation between CD19+ in patients group and the
follow up HB grading score emphasizing the role of CD19+
in this context. Furthermore, the CD19+ percent was nega-
tively correlated with the follow up latencies of R1 and ipsilat-
eral R2 of the blink reﬂex in the affected side. Both
correlations suggest that B cells appear to be a decisive factor
with respect to the prognosis of BP.
Studying the changes of the immune system in patients with
BP was a point of interest for many researches with controver-
sial results regarding the ﬁndings and interpretations.7,21,32,48,49
Jonsson et al. analyzed T lymphocytes and their subsets in 20
BP patients and found a decrease in the total T cell percentage
and T helper cells (CD4+) (as the present study). But unlike
ours they found no change in the percent of the cytotoxic T cells
(CD8+). After 4–6 weeks these depressions were restored to
normal levels.48 In our study all increased on follow up but
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(data not shown). In another study performed by Aveil et al.
the results were similar to ours.21 Also Vedeler et al. found a
signiﬁcant decrease of the mean percent of the active and total
T cells in the ﬁrst week in BP patients among whom 8 patients
showed a decreased percent of T suppressor cells and all re-
turned to the normal values after 3 months of the disease onse-
t49On the other hand, Kaygusuz et al. studied the role of viruses
and cellular immune response in idiopathic facial palsy. They
demonstrated that the percent of CD4+(similar to our results)
and CD4+/CD8+ ratios was lower while the percent of natu-
ral killer (NK) cells and CD8+ percent was higher than con-
trols (unlike our results) and CD19+ percent was normal
(similar to the present study)7They suggested that this pattern
was similar to viral reactivation. Alternatively, Tekgul et al.
found decreased CD19+ cells (unlike ours) and decreased
CD8+ T cells in children with BP. They suggested that the
underlying mechanism was an autoimmune process resulting
from decreased viral clearance due to decreased CD19+ as well
as delayed viral clearance due to viral induced CD4+ lympho-
penia with subsequent autoimmune process.32 Thus it can be
concluded from these studies (including our study) that there
is no stereotyped consistent cellular immune response among
BP patients and no consensus about the underlying operating
mechanism(s). These differences may be attributed to the vari-
ability in the designs of these studies. However, this conﬂict
may have its implication on management of those patients.
Although the studied patients exhibited signiﬁcant
improvement of their mean follow up HB score, yet the ENoG,
blink reﬂex and CMAP of the facial muscles improved but not
to a signiﬁcant level. In several studies, histological analysis of
facial nerve in BP revealed a mixed lesion of various nerve
injuries i.e. intact, demyelinated and degenerated nerves.50–52
It was also found that inﬂammation of the nerve initially leads
to reversible neurapraxia but ultimately Wallarian degenera-
tion occurs10Thus, it could be assumed that the recovery of
the demyelinated ﬁbers enhanced by medical treatment with
or without a possible regeneration of the degenerated ﬁbers
(if the conditions were favorable and the pathology was axo-
notemesis), all of which can improve the function sizably par-
ticularly if demyelination is the predominant pathology. On
the contrary, improvement of CMAP and ENoG depends so-
lely on regeneration of the degenerated ﬁbers which may take a
longer time and need optimal tissue conditions to take place.
Hence, rapid and sizable improvement of CMAP and ENoG
is unlikely compared to HB. This assumption is conﬁrmed
and can be explained by the signiﬁcant improvement of HB
score in patients with axonopathy on follow up assessment
(data not shown, P= 0.014). Moreover, the inherent nature
of ENoG makes it susceptible to variabilities including imped-
ance, electrode location, skin resistance, different distribution
of muscle mass and the patient’s tolerance level to the stimulus
intensity.27,53 Therefore its results should be interpreted cau-
tiously. The discrepancy between the improvement of HB
and ENoG was further conﬁrmed by the lack of correlations
between the follow up HB and ENoG among patients.
Blink reﬂex has the advantage over ENoG and facial nerve
conduction in being able to examine the proximal part of the
facial nerve in BP.28 However, there was no signiﬁcant
improvement on comparing its initial and follow up parame-
ters. This can be explained on the same basis as ENoG i.e.
the concept of a mixed nerve lesion in BP. It is to be noted thatsome patients who were grade VI on HB had initial normal
latencies of the blink reﬂex. This may be explained by the pres-
ence of few intact nerve ﬁbers which could convey impulses but
were not sufﬁcient to perform functional movement. Our re-
sults regarding ENoG were consistent with that of Honda
et al. who found that the ENoG recovery tended to be delayed
compared to clinical recovery in BP.51 Also in another study
ENoG failed to provide accurate information regarding the
prognosis or the rate of recovery in BP as it had no correlation
with the probability of recovery in such patients54However,
unlike our results R1 of the blink reﬂex paralleled the recovery
of facial paralysis well.51,55 In this study, patients were divided
into those with demyelination, and those with axonal degener-
ation of the facial nerve according to the initial electrophysio-
logical study which was conﬁrmed later on by improved HB
grading on follow up. Four patients with demyelination recov-
ered within 7 to 10 days, while the remaining one recovered
completely after 8 weeks. It is to be noted in this study that
there was uneven involvement of the facial nerve branches as
far as the pathology is concerned (judged by the EMG and
ENoG) i.e. some patients showed features of axonopathy in
some muscles and demyelination in others and even one pa-
tient with demyelinating lesion and who recovered completely
after 10 days, had a signiﬁcant decrease in ENoG of the lower
face muscles namely, nasalis and OOr. This implies that ENoG
may give false positive results denoting axonal degeneration
(particularly in absence of EMG abnormalities).
Some follow up electrophysiological parameters were corre-
lated with the initial percentage of the immune cells in periph-
eral blood of the studied patients signifying some prognostic
value of these cells. The initial CD8+ T cells percentage was
positively and signiﬁcantly correlated with the follow up values
of OOr CMAP amplitude and the ENoG of nasalis and OOc
muscles of the affected side. This emphasizes the role of
CD8+ cells in clearing the virus after reactivation (a window
of opportunity for the immune system)56and improving
inﬂammation and hence promoting recovery of the nerve i.e.
increasing the number of functioning ﬁbers and hence increas-
ing the ENoG and CMAP. Also the initial CD4+ T cells were
signiﬁcantly and negatively correlated with the disease dura-
tion implying that increased percentage of CD4+ cells will
promote recovery by virtue of its role in controlling viral reac-
tivation or autoimmunity as proposed mechanisms for BP and
thus shorten the disease duration. From this study it can be
concluded that decreased percentage of the peripheral blood
CD3+, CD4+ & CD8+ subsets in BP patients together with
increased B subset in patients with demyelination emphasize
the role of cell mediated and humoral immunity in the patho-
genesis of BP. These cells have some prognostic signiﬁcance
regarding disease duration and facial nerve recovery. Analysis
of T lymphocytes subsets (especially B cells) may provide an
additional parameter to differentiate patients with favorable
from those with poor prognosis.References
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